In this regard, in a model of type 2 diabetes, dapagliflozin decreased the renal expression of the renin–angiotensin system (RAS), oxidative stress, renal inflammation, and fibrosis [35]. The gene discussed is REN; the disease is type 2 diabetes mellitus.